Diffusion-weighted MRI for detecting and monitoring cancer: A review of current applications in body imaging

Diagnostic and Interventional Radiology

Volumn 18, Issue 1, 2012, Pages 46-59

  Türkbey, Bariş ^a   Aras, Ömer ^a   Karabulut, Nevzat ^b   Turgut, Ahmet Tuncay ^c   Akpinar, Erhan ^d   Alibek, Sedat ^e   Pang, Yuxi ^f   Ertürk, Şükrü Mehmet ^g   Khouli, Riham H El ^g   Bluemke, David A ^h   Choyke, Peter L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c Ankara Training and Education Hospital ^*  (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f PHILIPS HEALTHCARE   (United States)

^g SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^h NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Body applications; Cancer; Diffusion weighted magnetic resonance imaging

Indexed keywords

ABDOMINAL CANCER; ARTICLE; BODY REGIONS; BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER RECURRENCE; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; ENDOMETRIUM TUMOR; HUMAN; IMAGE ANALYSIS; LUNG CANCER; LUNG EXAMINATION; OVARY CANCER; PATIENT MONITORING; PROCESS OPTIMIZATION; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; UTERUS CANCER;

ABDOMINAL NEOPLASMS; BREAST NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; NEOPLASMS; PELVIC NEOPLASMS; THORACIC NEOPLASMS;

EID: 84855419748     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: 10.4261/1305-3825.DIR.4708-11.2     Document Type: Article

References (142)

1. Vilanova JC, Barcelo J. Diffusion-weighted whole-body MR screening. Eur J Radiol 2008; 67:440-447.
2. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007; 188:1622-1635.
3. Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR. Diffusionweighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008; 18:1937-1952.
4. Koh DM, Takahara T, Imai Y, Collins DJ. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. Magn Reson Med Sci 2007; 6:211-224.
5. Thoeny HC, De Keyzer F. Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur Radiol 2007; 17:1385-1393.
6. Provenzale JM, Mukundan S, Barboriak DP. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006; 239:632-649.
7. Stejskal EO, Tanner JE. Spin diffusion measurements: spin-echo in the presence of a time dependent field gradient. J Chem Phys 1965; 42:288-292.
8. Dietrich O, Biffar A, Baur-Melnyk A, Reiser MF. Technical aspects of MR diffusion imaging of the body. Eur J Radiol 2010; 76:314-322.
9. Braren R, Altomonte J, Settles M, et al. Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization. J Hepatol 2011; Feb 24 [Epub ahead of print]
10. Oner AY, Celik H, Oktar SO, Tali T. Single breath-hold diffusion-weighted MRI of the liver with parallel imaging: initial experience. Clin Radiol 2006; 61:959-965.
11. Taouli B, Martin AJ, Qayyum A, et al. Parallel imaging and diffusion tensor imaging for diffusion-weighted MRI of the liver: preliminary experience in healthy volunteers. AJR Am J Roentgenol 2004; 183:677-680.
12. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22:275-282.
13. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168:497-505.
14. Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study. Radiology 2008; 249:891-899.
15. Riches SF, Payne GS, Morgan VA, et al. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters. AJR Am J Roentgenol 2009; 193:1583-1591.
16. Lemke A, Laun FB, Simon D, Stieltjes B, Schad LR. An in vivo verification of the intravoxel incoherent motion effect in diffusion-weighted imaging of the abdomen. Magn Reson Med 2010; 64:1580-1585.
17. Sigmund EE, Cho GY, Kim S, et al. Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magn Reson Med 2011; 65:1437-1447.
18. Uhl M, Altehoefer C, Kontny U, Il'yasov K, Buchert M, Langer M. MRI-diffusion imaging of neuroblastomas: first results and correlation to histology. Eur Radiol 2002; 12:2335-2338.
19. Humphries PD, Sebire NJ, Siegel MJ, Olsen OE. Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology 2007; 245:848-854.
20. Alibek S, Cavallaro A, Aplas A, Uder M, Staatz G. Diffusion weighted imaging of pediatric and adolescent malignancies with regard to detection and delineation: initial experience. Acad Radiol 2009; 16:866-871.
21. Uhl M, Saueressig U, Koehler G, et al. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas. Pediatr Radiol 2006; 36:1306-1311.
22. Kwee TC, Takahara T, Vermoolen MA, Bierings MB, Mali WP, Nievelstein RA. Whole-body diffusion-weighted imaging for staging malignant lymphoma in children. Pediatr Radiol 2010; 40:1592-1602.
23. Karabulut N, Martin DR, Yang M, Tallaksen RJ. MR imaging of the chest using a contrast-enhanced breath-hold modified three-dimensional gradientecho technique: comparison with twodimensional gradient-echo technique and multidetector CT. AJR Am J Roentgenol 2002; 179:1225-1233.
24. Kanauchi N, Oizumi H, Honma T, et al. Role of diffusion-weighted magnetic resonance imaging for predicting of tumor invasiveness for clinical stage IA nonsmall cell lung cancer. Eur J Cardiothorac Surg 2009; 35:706-710; discussion 710-701.
25. Luna A, Sanchez-Gonzalez J, Caro P. Diffusion-weighted imaging of the chest. Magn Reson Imaging Clin N Am 2011; 19:69-94.
26. Kosucu P, Tekinbas C, Erol M, et al. Mediastinal lymph nodes: assessment with diffusion-weighted MR imaging. J Magn Reson Imaging 2009; 30:292-297.
27. Matoba M, Tonami H, Kondou T, et al. Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient. Radiology 2007; 243:570-577.
28. Liu H, Liu Y, Yu T, Ye N. Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions. Eur Radiol 2010; 20:807-815.
29. Uto T, Takehara Y, Nakamura Y, et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology 2009; 252:247-254.
30. Mori T, Nomori H, Ikeda K, et al. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. J Thorac Oncol 2008; 3:358-364.
31. Karabulut N. Accuracy of diffusionweighted MR imaging for differentiation of pulmonary lesions. Radiology 2009; 253:899; author reply 899-900.
32. Qi LP, Zhang XP, Tang L, Li J, Sun YS, Zhu GY. Using diffusion-weighted MR imaging for tumor detection in the collapsed lung: a preliminary study. Eur Radiol 2009; 19:333-341.
33. Baysal T, Mutlu DY, Yologlu S. Diffusionweighted magnetic resonance imaging in differentiation of postobstructive consolidation from central lung carcinoma. Magn Reson Imaging 2009; 27:1447-1454.
34. Nakayama J, Miyasaka K, Omatsu T, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr 2010; 34:1-8.
35. Nomori H, Mori T, Ikeda K, et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg 2008; 135:816-822.
36. Satoh S, Kitazume Y, Ohdama S, Kimula Y, Taura S, Endo Y. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? AJR Am J Roentgenol 2008; 191:464-470.
37. Koyama H, Ohno Y, Aoyama N, et al. Comparison of STIR turbo SE imaging and diffusion-weighted imaging of the lung: capability for detection and subtype classification of pulmonary adenocarcinomas. Eur Radiol 2010; 20:790-800.
38. Nakayama J, Miyasaka K, Omatsu T, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr 2010; 34:1-8.
39. Ohba Y, Nomori H, Mori T, et al. Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer? J Thorac Cardiovasc Surg 2009; 138:439-445.
40. Englander SA, Ulug AM, Brem R, Glickson JD, van Zijl PC. Diffusion imaging of human breast. NMR Biomed 1997; 10:348-352.
41. Sinha S, Lucas-Quesada FA, Sinha U, DeBruhl N, Bassett LW. In vivo diffusionweighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 2002; 15:693-704.
42. Bogner W, Gruber S, Pinker K, et al. Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology 2009; 253:341-351.
43. Pereira FP, Martins G, Figueiredo E, et al. Assessment of breast lesions with diffusion-weighted MRI: comparing the use of different b values. AJR Am J Roentgenol 2009; 193:1030-1035.
44. Baron P, Dorrius MD, Kappert P, Oudkerk M, Sijens PE. Diffusion-weighted imaging of normal fibroglandular breast tissue: influence of microperfusion and fat suppression technique on the apparent diffusion coefficient. NMR Biomed 2010; 23:399-405.
45. Thoeny HC, De Keyzer F, Boesch C, Hermans R. Diffusion-weighted imaging of the parotid gland: Influence of the choice of b-values on the apparent diffusion coefficient value. J Magn Reson Imaging 2004; 20:786-790.
46. Costantini M, Belli P, Rinaldi P, et al. Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness. Clin Radiol 2010; 65:1005-1012.
47. Jeh SK, Kim SH, Kim HS, et al. Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma. J Magn Reson Imaging 2011; 33:102-109.
48. El Khouli RH, Jacobs MA, Mezban SD, et al. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology 2010; 256:64-73.
49. Partridge SC, McKinnon GC, Henry RG, Hylton NM. Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI. J Magn Reson Imaging 2001; 14:433-438.
50. Sharma U, Danishad KK, Seenu V, Jagannathan NR. Longitudinal study of the assessment by MRI and diffusionweighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009; 22:104-113.
51. Park SH, Moon WK, Cho N, et al. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology 2010; 257:56-63.
52. Woodhams R, Kakita S, Hata H, et al. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging-comparison with contrast-enhanced MR imaging and pathologic findings. Radiology 2010; 254:357-366.
53. Nilsen L, Fangberget A, Geier O, Olsen DR, Seierstad T. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Acta Oncol 2010; 49:354-360.
54. Schmidt GP, Kramer H, Reiser MF, Glaser C. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology. Top Magn Reson Imaging 2007; 18:193-202.
55. Charles-Edwards EM, deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 2006; 6:135-143.
56. Goshima S, Kanematsu M, Kondo H, et al. Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging 2008; 28:691-697.
57. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echoplanar MR imaging sequences: prospective study in 66 patients. Radiology 2003; 226:71-78.
58. Oruç E, Yildirim N, Topal NB, Kiliçturgay S, Akgöz S, Savci G. The role of diffusionweighted MRI in the classification of liver hydatid cysts and differentiation of simple cysts and abscesses from hydatid cysts. Diagn Interv Radiol 2010; 16:279-287.
59. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008; 246:812-822.
60. Holzapfel K, Bruegel M, Eiber M, et al. Characterization of small (
61. Xia D, Jing J, Shen H, Wu J. Value of diffusion-weighted magnetic resonance images for discrimination of focal benign and malignant hepatic lesions: a metaanalysis. J Magn Reson Imaging 2010; 32:130-137.
62. Xu H, Li X, Xie JX, Yang ZH, Wang B. Diffusion-weighted magnetic resonance imaging of focal hepatic nodules in an experimental hepatocellular carcinoma rat model. Acad Radiol 2007; 14:279-286.
63. Vandecaveye V, De Keyzer F, Verslype C, et al. Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol 2009; 19:2456-2466.
64. Feuerlein S, Pauls S, Juchems MS, et al. Pitfalls in abdominal diffusion-weighted imaging: how predictive is restricted water diffusion for malignancy. AJR Am J Roentgenol 2009; 193:1070-1076.
65. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006; 239:122-130.
66. Spiotta AM, Bhalla T, Hussain MS, et al. An analysis of inflation times during balloon-assisted aneurysm coil embolization and ischemic complications. Stroke 2011; 42:1051-1055.
67. Theilmann RJ, Borders R, Trouard TP, et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 2004; 6:831-837.
68. Chan JH, Tsui EY, Luk SH, et al. Diffusionweighted MR imaging of the liver: distinguishing hepatic abscess from cystic or necrotic tumor. Abdom Imaging 2001; 26:161-165.
69. Yoshikawa T, Kawamitsu H, Mitchell DG, et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol 2006; 187:1521-1530.
70. Fattahi R, Balci NC, Perman WH, et al. Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging 2009; 29:350-356.
71. Muraoka N, Uematsu H, Kimura H, et al. Apparent diffusion coefficient in pancreatic cancer: characterization and histopathological correlations. J Magn Reson Imaging 2008; 27:1302-1308.
72. Erturk SM, Ichikawa T, Motosugi U, Sou H, Araki T. Diffusion-weighted MR imaging in the evaluation of pancreatic exocrine function before and after secretin stimulation. Am J Gastroenterol 2006; 101:133-136.
73. Inan N, Arslan A, Akansel G, Anik Y, Demirci A. Diffusion-weighted imaging in the differential diagnosis of cystic lesions of the pancreas. AJR Am J Roentgenol 2008; 191: 1115-1121.
74. Irie H, Honda H, Kuroiwa T, et al. Measurement of the apparent diffusion coefficient in intraductal mucin-producing tumor of the pancreas by diffusion-weighted echo-planar MR imaging. Abdom Imaging 2002; 27:82-87.
75. Fukuda Y, Ohashi I, Hanafusa K, et al. Anisotropic diffusion in kidney: apparent diffusion coefficient measurements for clinical use. J Magn Reson Imaging 2000; 11:156-160.
76. Zhang J, Tehrani YM, Wang L, Ishill NM, Schwartz LH, Hricak H. Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience. Radiology 2008; 247:458-464.
77. Manenti G, Di Roma M, Mancino S, et al. Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T. Radiol Med 2008; 113:199-213.
78. Paudyal B, Paudyal P, Tsushima Y, et al. The role of the ADC value in the characterisation of renal carcinoma by diffusionweighted MRI. Br J Radiol 2010; 83:336-343.
79. Miller FH, Wang Y, McCarthy RJ, et al. Utility of diffusion-weighted MRI in characterization of adrenal lesions. AJR Am J Roentgenol 2010; 194:W179-185.
80. Cui XY, Chen HW. Role of diffusionweighted magnetic resonance imaging in the diagnosis of extrahepatic cholangiocarcinoma. World J Gastroenterol 2010; 16:3196-3201.
81. Satoh Y, Ichikawa T, Motosugi U, et al. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrastenhanced MDCT. AJR Am J Roentgenol 2011; 196:447-453.
82. Lim HK, Kim JK, Kim KA, Cho KS. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection- a multireader study. Radiology 2009; 250:145-151.
83. Tamada T, Sone T, Toshimitsu S, et al. Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues. J Magn Reson Imaging 2008; 27:552-556.
84. Kim CK, Park BK, Lee HM, Kwon GY. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Invest Radiol 2007; 42:842-847.
85. Kitajima K, Kaji Y, Kuroda K, Sugimura K. High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-tonoise ratio. Magn Reson Med Sci 2008; 7:93-99.
86. Gibbs P, Pickles MD, Turnbull LW. Diffusion imaging of the prostate at 3.0 tesla. Invest Radiol 2006; 41:185-188.
87. Tamada T, Sone T, Jo Y, et al. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology 2008; 248:531-539.
88. Yaǧci AB, Ozari N, Aybek Z, Düzcan E. The value of diffusion-weighted MRI for prostate cancer detection and localization. Diagn Interv Radiol 2011; 17:130-134.
89. Haider MA, van der Kwast TH, Tanguay J, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007; 189:323-328.
90. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology. J Magn Reson Imaging 2006; 24:108-113.
91. Reinsberg SA, Payne GS, Riches SF, et al. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 2007; 188:91-98.
92. Mazaheri Y, Shukla-Dave A, Hricak H, et al. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. Radiology 2008; 246:480-488.
93. Tamada T, Sone T, Jo Y, et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 2008; 28:720-726.
94. deSouza NM, Riches SF, Vanas NJ, et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 2008; 63:774-782.
95. Mazaheri Y, Hricak H, Fine SW, et al. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 2009; 252:449-457.
96. Van As N, Charles-Edwards E, Jackson A, et al. Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimens. Br J Radiol 2008; 81:456-462.
97. Somford DM, Futterer JJ, Hambrock T, Barentsz JO. Diffusion and perfusion MR imaging of the prostate. Magn Reson Imaging Clin N Am 2008; 16:685-695.
98. Matsuki M, Inada Y, Tatsugami F, Tanikake M, Narabayashi I, Katsuoka Y. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol 2007; 17:201-204.
99. El-Assmy A, Abou-El-Ghar ME, Refaie HF, El-Diasty T. Diffusion-weighted MR imaging in diagnosis of superficial and invasive urinary bladder carcinoma: a preliminary prospective study. ScientificWorld Journal 2008; 8:364-370.
100. Abou-El-Ghar ME, El-Assmy A, Refaie HF, El-Diasty T. Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology 2009; 251:415-421.
101. Watanabe H, Kanematsu M, Kondo H, et al. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? AJR Am J Roentgenol 2009; 192:1361-1366.
102. Takeuchi M, Sasaki S, Ito M, et al. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009; 251:112-121.
103. Kilickesmez O, Cimilli T, Inci E, et al. Diffusion-weighted MRI of urinary bladder and prostate cancers. Diagn Interv Radiol 2009; 15:104-110.
104. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11:102-125.
105. Whittaker CS, Coady A, Culver L, Rustin G, Padwick M, Padhani AR. Diffusionweighted MR imaging of female pelvic tumors: a pictorial review. Radiographics 2009; 29:759-774; discussion 774-758.
106. Takeuchi M, Matsuzaki K, Nishitani H. Manifestations of the female reproductive organs on MR images: changes induced by various physiologic states. Radiographics 2010; 30:1147.
107. Kido A, Kataoka M, Koyama T, Yamamoto A, Saga T, Togashi K. Changes in apparent diffusion coefficients in the normal uterus during different phases of the menstrual cycle. Br J Radiol 2010; 83:524-528.
108. Masroor I, Zeeshan M, Afzal S, Ahmad N, Shafqat G. Diffusion weighted MR imaging (DWI) and ADC values in endometrial carcinoma. J Coll Physicians Surg Pak 2010; 20:709-713.
109. Wang J, Yu T, Bai R, Sun H, Zhao X, Li Y. The value of the apparent diffusion coefficient in differentiating stage IA endometrial carcinoma from normal endometrium and benign diseases of the endometrium: initial study at 3-T magnetic resonance scanner. J Comput Assist Tomogr 2010; 34:332-337.
110. Wang LX, Zhou CW, Ouyang H. Value of high-field MR diffusion-weighted MR imaging in the diagnosis of endometrial carcinoma. Zhonghua Zhong Liu Za Zhi 2009; 31:849-853.
111. Takeuchi M, Matsuzaki K, Nishitani H. Diffusion-weighted magnetic resonance imaging of endometrial cancer: differentiation from benign endometrial lesions and preoperative assessment of myometrial invasion. Acta Radiol 2009; 50:947-953.
112. Kilickesmez O, Bayramoglu S, Inci E, Cimilli T, Kayhan A. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones. Acta Radiol 2009; 50:340-347.
113. Inada Y, Matsuki M, Nakai G, et al. Body diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging? Eur J Radiol 2009; 70:122-127.
114. Fujii S, Matsusue E, Kigawa J, et al. Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results. Eur Radiol 2008; 18:384-389.
115. Shen SH, Chiou YY, Wang JH, et al. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 2008; 190:481-488.
116. Tamai K, Koyama T, Saga T, et al. Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 2007; 26:682-687.
117. Rechichi G, Galimberti S, Signorelli M, Perego P, Valsecchi MG, Sironi S. Myometrial invasion in endometrial cancer: diagnostic performance of diffusionweighted MR imaging at 1.5-T. Eur Radiol 2010; 20:754-762.
118. Nicolet V, Carignan L, Bourdon F, Prosmanne O. MR imaging of cervical carcinoma: a practical staging approach. Radiographics 2000; 20:1539-1549.
119. Chen YB, Hu CM, Chen GL, Hu D, Liao J. Staging of uterine cervical carcinoma: whole-body diffusion-weighted magnetic resonance imaging. Abdom Imaging 2010; Aug 21 [Epub ahead of print]
120. Hoogendam JP, Klerkx WM, de Kort GA, et al. The influence of the b-value combination on apparent diffusion coefficient based differentiation between malignant and benign tissue in cervical cancer. J Magn Reson Imaging 2010; 32:376-382.
121. Liu Y, Bai R, Sun H, Liu H, Wang D. Diffusion-weighted magnetic resonance imaging of uterine cervical cancer. J Comput Assist Tomogr 2009; 33:858-862.
122. Payne GS, Schmidt M, Morgan VA, et al. Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer. Gynecol Oncol 2010; 116:246-252.
123. Chen J, Zhang Y, Liang B, Yang Z. The utility of diffusion-weighted MR imaging in cervical cancer. Eur J Radiol 2010; 74:e101-106.
124. McVeigh PZ, Syed AM, Milosevic M, Fyles A, Haider MA. Diffusion-weighted MRI in cervical cancer. Eur Radiol 2008; 18:1058-1064.
125. Zhang Y, Liang BL, Gao L, Ye RX, Shen J, Zhong JL. Diffusion weighted imaging features of normal uterine cervix and cervical carcinoma. Ai Zheng 2007; 26:508-512.
126. Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, Takizawa O. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 2005; 15:71-78.
127. Liu Y, Bai R, Sun H, Liu H, Zhao X, Li Y. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation. Clin Radiol 2009; 64:1067-1074.
128. Harry VN, Semple SI, Gilbert FJ, Parkin DE. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 2008; 111:213-220.
129. Chen YB, Liao J, Xie R, Chen GL, Chen G. Discrimination of metastatic from hyperplastic pelvic lymph nodes in patients with cervical cancer by diffusion-weighted magnetic resonance imaging. Abdom Imaging 2009; 36:102-109.
130. Park SO, Kim JK, Kim KA, et al. Relative apparent diffusion coefficient: determination of reference site and validation of benefit for detecting metastatic lymph nodes in uterine cervical cancer. J Magn Reson Imaging 2009; 29:383-390.
131. Kim JK, Kim KA, Park BW, Kim N, Cho KS. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. J Magn Reson Imaging 2008; 28:714-719.
132. Lin G, Ho KC, Wang JJ, et al. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T. J Magn Reson Imaging 2008; 28:128-135.
133. Roy C, Bierry G, Matau A, Bazille G, Pasquali R. Value of diffusion-weighted imaging to detect small malignant pelvic lymph nodes at 3 T. Eur Radiol 2010; 20:1803-1811.
134. Nakai G, Matsuki M, Inada Y, et al. Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging. J Comput Assist Tomogr 2008; 32:764-768.
135. Takeuchi M, Matsuzaki K, Nishitani H. Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses. J Comput Assist Tomogr 2010; 34:173-176.
136. Fujii S, Kakite S, Nishihara K, et al. Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions. J Magn Reson Imaging 2008; 28:1149-1156.
137. Bakir B, Bakan S, Tunaci M, et al. Diffusion-weighted imaging of solid or predominantly solid gynaecological adnexial masses: is it useful in the differential diagnosis? Br J Radiol 2011; 84:600-611.
138. Busard MP, Mijatovic V, van Kuijk C, Pieters-van den Bos IC, Hompes PG, van Waesberghe JH. Magnetic resonance imaging in the evaluation of (deep infiltrating) endometriosis: the value of diffusionweighted imaging. J Magn Reson Imaging 2010; 32:1003-1009.
139. Sala E, Rockall A, Rangarajan D, Kubik-Huch RA. The role of dynamic contrastenhanced and diffusion weighted magnetic resonance imaging in the female pelvis. Eur J Radiol 2010; 76:367-385.
140. Nakayama T, Yoshimitsu K, Irie H, et al. Diffusion-weighted echo-planar MR imaging and ADC mapping in the differential diagnosis of ovarian cystic masses: usefulness of detecting keratinoid substances in mature cystic teratomas. J Magn Reson Imaging 2005; 22:271-278.
141. Katayama M, Masui T, Kobayashi S, et al. Diffusion-weighted echo planar imaging of ovarian tumors: is it useful to measure apparent diffusion coefficients? J Comput Assist Tomogr 2002; 26:250-256.
142. Kyriazi S, Collins DJ, Morgan VA, Giles SL, deSouza NM. Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer. Radiographics 2010; 30:1269-1285.